We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
U.S.-based Abbott Laboratories announced it is implementing a new program aimed at expanding access to its new HIV drug, Aluvia (lopinavir/ritonavir), in the developing world.
A meeting of the Expert Consultation on Pediatric Essential Medicines in Geneva, jointly held by the World Health Organization (WHO) and the United Nation's Children's Fund (UNICEF), resulted in a plan to boost access to essential medicines for children.
The director of Vietnam's Pharmaceutical Management Department, Cao Minh Quang, said that the country's pharmaceutical manufacturers will soon face closure if they fail to meet international standards on drug production.
Before Bristol-Myers Squibb announced its plans to establish a major pharmaceutical manufacturing facility at Devens, the state agreed to a number of incentives, which included paying the facility's permitting costs.
The Directors of BresaGen Limited ("BresaGen") are pleased to announce that they have received an off market takeover offer for all of the issued capital in BresaGen from Hospira Holdings (S.A.) Pty Ltd ("Hospira"), a wholly owned subsidiary of Hospira, Inc.
San Diego-based drug discovery and development company BrainCells Inc. has in-licensed a clinical-stage compound from Mitsubishi Pharma Corp. (MPC) that BCI will reposition and develop for the treatment of central nervous system (CNS) diseases, including mood disorders.
Sami Labs, the herbal nutraceutical major, has received the permission from the Drugs Controller General of India to manufacture and market the new drug for Glaucoma developed from Forskolin that is a one percent ophthalmic solution.